End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.73 EUR | +0.41% | +1.35% | -4.22% |
Jul. 09 | Takeda Issues New Shares, Disposes of Treasury Shares Under Incentive Scheme | MT |
Jul. 03 | Blackstone selling Japan drugmaker Alinamin to MBK Partners | RE |
Chart calendar Takeda Pharmaceutical Company Limited
Upcoming events on Takeda Pharmaceutical Company Limited
Past events on Takeda Pharmaceutical Company Limited
2024-06-25 09:00 pm | Shareholders Meeting |
2024-06-22 | Peripheral Nerve Society Meeting |
2024-06-03 08:30 pm | Sleep Meeting |
2024-05-09 06:00 am | Q4 2023 Earnings Call |
2024-05-09 02:07 am | Q4 2023 Earnings Release |
2024-03-27 | Final dividend |
2024-03-06 09:50 am | TD Cowen Health Care Conference |
2024-02-01 05:59 am | Q3 2023 Earnings Release |
2024-02-01 05:30 am | Q3 2023 Earnings Call |
2024-01-08 08:15 pm | JPMorgan Healthcare Conference |
2023-12-08 | American Society of Hematology Meeting |
2023-12-05 06:00 pm | Analyst Meeting - Plasma-Derived Therapies (PDT) |
2023-11-14 12:00 pm | American College of Rheumatology Conference - Abstract Number - L12 |
2023-11-14 04:00 am | Jefferies London Healthcare Conference |
2023-10-26 06:00 am | Q2 2023 Earnings Call |
2023-10-26 02:00 am | Q2 2023 Earnings Release |
2023-09-27 | Détachement de for dividende intermédiaire |
2023-09-11 03:35 pm | Morgan Stanley Healthcare Conference |
2023-07-27 06:00 am | Q1 2023 Earnings Call |
2023-07-27 02:00 am | Q1 2023 Earnings Release |
Past dividends on Takeda Pharmaceutical Company Limited
2024-03-27 | Final Payment 94 JPY |
2023-09-27 | Interim Payment 94 JPY |
2023-03-29 | Final Payment 90 JPY |
2022-09-28 | Interim Payment 90 JPY |
2022-03-29 | Final Payment 90 JPY |
2021-09-28 | Interim Payment 90 JPY |
2021-03-29 | Final Payment 90 JPY |
2020-09-28 | Interim Payment 90 JPY |
2020-03-29 | Final Payment 90 JPY |
2019-09-26 | Interim Payment 90 JPY |
Annual results
Fiscal Period | March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 3 291 200 3 317 708 -0.8% | 3 197 812 3 220 743 -0.71% | 3 569 006 3 490 146 2.26% | 4 027 478 3 985 941 1.04% | 4 263 762 4 099 317 4.01% | 4 289 362 |
EBITDA Million JPY | Released Forecast Spread | 684 057 779 587 -12.25% | 1 068 940 1 159 038 -7.77% | 1 043 995 1 144 518 -8.78% | 1 154 905 1 252 287 -7.78% | 942 077 1 046 202 -9.95% | 1 094 081 |
EBIT Million JPY | Released Forecast Spread | 100 400 37 690 166.38% | 509 269 546 585 -6.83% | 460 844 510 133 -9.66% | 490 505 538 048 -8.84% | 214 100 267 999 -20.11% | 289 078 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -60 754 -181 179 66.47% | 366 235 435 452 -15.9% | 302 571 382 708 -20.94% | 375 090 427 128 -12.18% | 52 791 132 641 -60.2% | 111 830 |
Net income Million JPY | Released Forecast Spread | 44 200 -142 632 130.99% | 376 005 293 971 27.91% | 230 059 238 921 -3.71% | 317 017 314 672 0.75% | 144 067 134 659 6.99% | 114 718 |
EPS JPY | Released Forecast Spread | 28,0 -87,6 131.97% | 241 166 44.73% | 147 153 -3.85% | 204 203 0.77% | 92,1 88,9 3.56% | 72,2 |
Announcement Date | 13/05/20 | 11/05/21 | 11/05/22 | 11/05/23 | 09/05/24 | - |
Quarterly results
Fiscal Period | Marzo | 2020 S2 | 2021 S1 | 2022 S1 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 S1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 1 631 000 1 622 217 0.54% | 1 590 785 1 614 700 -1.48% | 1 794 400 1 799 800 -0.3% | 873 289 848 137 2.97% | 972 465 953 850 1.95% | 1 002 340 950 078 5.5% | 1 974 800 2 008 000 -1.65% | 1 096 551 996 345 10.06% | 956 200 954 896 0.14% | 1 058 618 995 797 6.31% | 1 043 089 990 336 5.33% | 2 101 707 2 062 000 1.93% | 1 111 200 1 000 980 11.01% | 1 050 869 899 902 16.78% | 1 073 113 | 1 080 400 | 2 126 400 | 1 139 257 | 1 062 529 | 1 064 000 | 2 137 000 |
EBITDA Million JPY | Released Forecast Spread | 249 972 | 340 072 | 133 355 | 291 975 347 150 -15.89% | 176 675 207 900 -15.02% | 320 925 | 282 725 | 368 925 | 202 525 | ||||||||||||
EBIT Million JPY | Released Forecast Spread | 50 100 -18 766 366.97% | 215 588 267 800 -19.5% | 346 000 357 150 -3.12% | -1 619 61 374 -102.64% | 150 515 166 025 -9.34% | 104 485 118 969 -12.17% | 255 000 302 000 -15.56% | 146 990 180 100 -18.38% | 88 600 118 453 -25.2% | 168 571 130 200 29.47% | -49 341 93 028 -153.04% | 119 230 257 950 -53.78% | 104 900 59 467 76.4% | -10 055 50 750 -119.81% | 95 680 | 73 125 | 137 550 | 74 350 | 19 425 | 121 000 | 239 500 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -33 197 -89 335 62.84% | 125 561 209 500 -40.07% | 284 425 269 500 5.54% | -54 047 33 814 -259.84% | 155 473 143 488 8.35% | 64 549 49 844 29.5% | 220 022 278 000 -20.86% | 107 153 169 587 -36.82% | 47 900 59 386 -19.34% | 135 033 111 968 20.6% | -95 980 103 284 -192.93% | 39 053 211 450 -81.53% | 61 300 76 613 -19.99% | -47 500 18 376 -358.49% | 70 591 | 44 187 | 57 650 | 35 554 | -21 513 | 79 500 | 156 500 |
Net income Million JPY | Released Forecast Spread | 11 000 -188 647 105.83% | 86 548 134 840 -35.81% | 183 600 186 500 -1.55% | -11 358 15 964 -171.15% | 105 014 105 471 -0.43% | 61 786 39 044 58.25% | 166 800 197 400 -15.5% | 119 127 129 087 -7.72% | 31 100 28 220 10.21% | 89 395 88 267 1.28% | -48 030 93 784 -151.21% | 41 365 192 000 -78.46% | 105 700 86 163 22.68% | -3 000 -2 071 -44.86% | 64 391 | 40 154 | 59 800 | 33 654 | -15 713 | 61 000 | 120 500 |
EPS JPY | Released Forecast Spread | 55,5 72,7 -23.73% | 117 119 -1.6% | -6,95 5,97 -216.51% | 67,9 63,9 6.26% | 40,1 38,2 4.75% | 108 128 -15.43% | 76,7 97,7 -21.49% | 20,0 10,7 87.15% | 57,5 39,0 47.55% | -31,0 38,6 -180.36% | 26,5 | 67,4 21,7 211.01% | -1,92 17,7 -110.83% | 38,7 | 23,8 | 47,5 | 24,3 | -15,3 | 38,9 | 76,8 | |
Announcement Date | 13/05/20 | 29/10/20 | 28/10/21 | 11/05/22 | 28/07/22 | 27/10/22 | 27/10/22 | 02/02/23 | 11/05/23 | 27/07/23 | 26/10/23 | 26/10/23 | 01/02/24 | 09/05/24 | - | - | - | - | - | - | - |
2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | INNOVIVA, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Takeda Pharmaceutical Company Limited
2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2024-07-09 | LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release |
2024-07-09 07:35 am | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
2024-07-02 05:05 am | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4502 Stock
- TKD Stock
- Calendar Takeda Pharmaceutical Company Limited